Osaic Holdings’s Franklin Genomic Advancements ETF HELX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,630
| Closed | -$71K | – | 7353 |
|
|
2025
Q1 | $71K | Buy |
+2,630
| New | +$71K | ﹤0.01% | 4432 |
|
|
2024
Q4 | – | Sell |
-2
| Closed | -$66 | – | 7283 |
|
|
2024
Q3 | $66 | Sell |
2
-182
| -99% | -$6.01K | ﹤0.01% | 7046 |
|
|
2024
Q2 | $5.83K | Sell |
184
-113
| -38% | -$3.58K | ﹤0.01% | 5997 |
|
|
2024
Q1 | $9.73K | Sell |
297
-100
| -25% | -$3.28K | ﹤0.01% | 5683 |
|
|
2023
Q4 | $12.1K | Sell |
397
-82
| -17% | -$2.5K | ﹤0.01% | 5704 |
|
|
2023
Q3 | $13.6K | Sell |
479
-141
| -23% | -$4K | ﹤0.01% | 5733 |
|
|
2023
Q2 | $18.7K | Buy |
620
+505
| +439% | +$15.3K | ﹤0.01% | 5586 |
|
|
2023
Q1 | $3.5K | Sell |
115
-904
| -89% | -$27.5K | ﹤0.01% | 6413 |
|
|
2022
Q4 | $31K | Hold |
1,019
| – | – | ﹤0.01% | 5263 |
|
|
2022
Q3 | $30K | Buy |
1,019
+2
| +0.2% | +$59 | ﹤0.01% | 5285 |
|
|
2022
Q2 | $33K | Hold |
1,017
| – | – | ﹤0.01% | 5248 |
|
|
2022
Q1 | $38K | Hold |
1,017
| – | – | ﹤0.01% | 5267 |
|
|
2021
Q4 | $49K | Sell |
1,017
-88,027
| -99% | -$4.24M | ﹤0.01% | 5155 |
|
|
2021
Q3 | $4.66M | Buy |
89,044
+87,472
| +5,564% | +$4.58M | 0.01% | 1101 |
|
|
2021
Q2 | $81K | Buy |
1,572
+512
| +48% | +$26.4K | ﹤0.01% | 4653 |
|
|
2021
Q1 | $46K | Buy |
1,060
+505
| +91% | +$21.9K | ﹤0.01% | 4920 |
|
|
2020
Q4 | $25K | Buy |
+555
| New | +$25K | ﹤0.01% | 4984 |
|